SARS-COV2

Sharareh Mohammad Hasani1, Mahdi Behdani2, Zohreh Amirkhani1

  • 1Department of Genetics and Molecular Biology, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran.

PubMed
概括

显示SARS-CoV-2表位体的菌体作为辅助剂,增强小鼠的免疫反应. 这些重组菌体显示出开发针对SARS-CoV-2的注射和口服疫苗的前景.